Research on cardiac dysfunction after carbon-ion radiotherapy

UMIN ID: UMIN000055447

Registered date:09/09/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Esophageal cancer, Hepatocellular carcinoma, Intrahepatic bile duct cancer
• Date of first enrollment: 2024/09/10
• Target sample size: 30
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: Occurrence of Grade 3 or higher cardiac adverse events occurring between 3 and 24 months after the end of carbon-ion radhiotherapy

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1) People who cannot have an MRI scan due to claustrophobia, pacemakers, or magnetic metals in the body. 2) People with a history of contrast agent allergies, or people with low kidney function who cannot have a contrast MRI scan. 3) People with serious complications, or people who have a history of these complications and who are judged by the researcher to be unsuitable for this study. 4) Those who are pregnant or may be pregnant, or who are breastfeeding. 5) Others who are judged by the researcher to be unsuitable as a research subject.

Related Information

• Primary Sponsor: National Institutes for Quantum Science and Technology
• Source(s) of Monetary Support: National Institutes for Quantum Science and Technology